| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Leftwich Scott | Director | C/O CALIDI BIOTHERAPEUTICS, INC., 4475 EXECUTIVE DRIVE, SUITE 200, SAN DIEGO, | /s/ Andrew Jackson, Attorney-in-fact | 25 Aug 2025 | 0001991668 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CLDI | Common Stock | Purchase | $250,000 | +125,000 | +2212% | $2.00* | 130,650 | 21 Aug 2025 | Direct | F1, F2 |
| holding | CLDI | Common Stock | 14,672 | 21 Aug 2025 | By SECBL, LLC | F3 | |||||
| holding | CLDI | Common Stock | 1,309 | 21 Aug 2025 | By WEBCL, LLC | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CLDI | Warrant (right to buy) | Purchase | +125,000 | 125,000 | 21 Aug 2025 | Common stock | 125,000 | $2.00 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | The common stock and warrants were acquired by the reporting person in a public offering conducted by the Issuer that was closed on August 21, 2025. |
| F2 | Each common share was purchased with an accompanying warrant for a purchase price of $2.00 per share and accompanying warrant. |
| F3 | The reporting person is the managing member of SECBL, LLC and WEBCL, LLC, as such the reporting person may be deemed to have beneficial ownership of the common stock held by SECBL, LLC and WEBCL, LLC. |
Exhibit 24 - Power of Attorney (previously filed as Exhibit 24 to Form 4 dated July 2, 2024.)